nVerses Capital’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,800
Closed -$51.5K 1305
2024
Q2
$51.5K Buy
1,800
+1,600
+800% +$45.8K 0.03% 589
2024
Q1
$5.84K Buy
+200
New +$5.84K 0.01% 563